Ritedose

Jun 18, 2025

Ritedose Unveils State-of-the-Art Distribution and Logistics Facility at Ritedose Performance Park

May 20, 2025

Ritedose Pharmaceuticals Receives FDA Approval for Albuterol Sulfate Inhalation Solution, 0.5% (2.5 mg/0.5 mL)*--Addressing Nationwide Shortage of the Essential Drug

Apr 16, 2025

Ritedose Adds Seventh Syntegon Packaging Line to Expand Single Vial Packaging Capabilities, Support Production of new COPD Drug Ohtuvayre

Mar 06, 2025

Ritedose Expands Commitment to Service with 1,000 Hours of Purpose Initiative

Jan 21, 2025

Ritedose and Newberry College Forge Strategic Partnership to Launch Pharmaceutical Manufacturing Program

Sep 17, 2024

Ritedose is Proud to Partner with Verona Pharma to Deliver First-In-Class COPD Drug, Ohtuvayre (ensifentrine)*

Aug 12, 2024

Ritedose Pharmaceuticals Continues Tradition of Giving Back - Increases its Annual Donation to Unprecedented Amount of 1 Million Doses of Respiratory Medications to Dispensary of Hope for Low-income and Chronically lll Patients

Jun 20, 2024

Ritedose, the Leading Pharmaceutical Manufacturer (CDMO) Specializing in Sterile Blow-Fill-Seal, Expands its BFS Capacity to Meet the Growing Demand for Ophthalmic and Respiratory Medications